Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model

Company Bags $250m In Series A

• Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business